« FDA Issues Draft Documents on the Safety of Animal Clones | Main | FDA and States Closer to Identifying Source of E. coli »

FDA Approvals - Congress Likely To Debate Moratoriums On Direct-to-Consumer Prescription Drug Advertisements


Congress Likely To Debate Moratoriums On Direct-to-Consumer Prescription Drug Advertisements (Medical News Today)
Congress this session likely will debate the FDA review system for prescription drug direct-to-consumer advertisements during hearings on renewing user fees that manufactures pay the agency for quicker drug approvals, according to industry critics, the New York Times reports. [click link for full article]

Tm Bioscience to hold shareholder vote on proposed acquisition by Luminex on February 23, 2007 (CNW Group via Yahoo! Finance)
Tm Bioscience Corporation , a leader in the commercial genetic testing market, confirmed that the mailing of the definitive forms of proxy and Management Information Circular to holders of common shares and options, in connection with the proposed arrangement transaction with Luminex Corporation will occur today.
 

©2006 FDA-News.com. All rights reserved.